聂颖,张京娟,郭艳红,高炜

• 1:北京大学第三医院心内科 分子心血管学教育部重点实验室
• 2:北京大学第三医院心内科
• 3:分子心血管学教育部重点实验室
• 4:北京大学第三医院心内科

摘要(Abstract)：

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation): “十五”国家科技攻关计划(编号:2004BA714B05-01)

作者(Author): 聂颖,张京娟,郭艳红,高炜

参考文献(References)：

• [1]Galley HF,Webster NR.Physioligy of endothelium[cardiovas-cular disease in anaesthesia and critical care].Br J Anaeth,2004,93:105-113.
• [2]丛海霞,王学东,贾三庆.内皮功能和心血管事件.中国医药导刊,2006,8:18-20.
• [3]郭建友,霍海如,姜廷良.内皮细胞功能及异质性研究的进展.中国临床药理学与治疗学,2005,10:1081-1084.
• [4]Choi K,Kennedy M,Kazarov A,et al.A common precursor forhematopoietic and endothelial cells.Development,1998,125:725-732.
• [5]Gallagher G,Sumpio BE.Vascular endothelial cells//SumpioBE,Sidawy AS.Basic Science of Vascular Disease.Mt.Kisco:Futura Publishing Co,1997,151-186.
• [6]Galley HF,Blaylock MG,Dubbels AM,et al.Variability in E-selectin expression,mRNAlevels and sE-selectin release betweenendothelial cell lines and primary endothelial cells.Cell Biol Int,2000,24:91-99.
• [7]Werner N,Nickening G.Influence of cardiovascular risk factorson endothelial progenitor cells:limitations for therapy?Arterio-scler Thromb Vasc Biol,2006,26:257-266.
• [8]Schwartz SM,Benditt EP.Clustering of replicating cells in aorticendothelium.Proc Natl Acad Sci US A,1976,73:651-653.
• [9]Crosby JR,Kaminski WE,Schatteman G,et al.Endothelialcells of hematopoietic origin make a significant contribution to a-dult blood vessel formation.Circ Res,2000,87:728-730.
• [10]Werner N,Priller J,Laufs U,et al.Bone marrow-derived pro-genitor cells modulate vascular reendothelialization and neointimalformation:effect of3-hydroxy-3-methylglutaryl coenzyme a reduc-tase inhibition.Arterioscler Thromb Vasc Biol,2002,22:1567-1572.
• [11]Werner N,Junk S,Laufs U,et al.Intravenous transfusion of en-dothelial progenitor cells reduces neointima formation after vascu-lar injury.Circ Res,2003,93:e17-e24.
• [12]Michitak T,Mitsuhiko O,Denan J,et al.Granulocyte Colony-Stimulating Factor Mobilized Circulating c-Kit+/Flk-1+Progeni-tor Cells Regenerate Endothelium and Inhibit Neointimal Hyper-plasia After Vascular Injury.Arterioscler ThrombVasc Biol,2006,26:751-757.
• [13]Asahara T,Masuda H,Takahashi T,et al.Bone marrow originof endothelial progenitor cells responsible for postnatal vasculo-genesis in physiological and pathological neovascularization.CircRes,1999,85:221-228.
• [14]Fam NP,Verma S,Kutryk M,et al.Clinician guide to angio-genesis.Circulation,2003,108:2613-2618.
• [15]Goldschmidt-Clermont PJ.Loss of bone marrow-derived vascularprogenitor cells leads to inflammation and atherosclerosis.AmHeart J,2003,146:5-12.
• [16]Murohara T,Ikeda H,Duan J,et al.Transplanted cord blood-derived endothelial precursot cells augment postnatal neovascular-ization.J Clin Invest,2000,105:1527-1536.
• [17]Lambiase PD,Edwards RJ,Anthopoulos P,et al.Circulatinghumoral factors and endothelial progenitor cells in patients withdiffering coronary collateral support.Circulation,2004,109:2986-2992.
• [18]Skowasch D,Jabs A,Andrie R,et al.Presence of bone-marrowand neural-crest-derived cells in intimal hyperplasia at the timeof clinical in-stent restenosis.Cardiovasc Res.2003,60:684-691.
• [19]Vanderheyden M,Mansour S,Bartunek J,et al.Acceleratedatherosclerosis following intracoronary haematopoietic stem celladministration.Heart.2004,10:448.
• [20]Kang HJ,Kim HS,Zhang SH-Y,et al.Effects of intracoronaryinfusion of peripheral blood stem-cells mobilized with granulocy-ted-colony stimulating factor on left ventricular systolic functionand restenosis after coronary stenting in myocardial infarction:theMAGIC cell randomized clinical trial.Lancet,2004,363:751-756.
• [21]Aviles FF,Roman JAS,et al.Experimental and Clinical regen-erative capability of human bone marrowcells after myocardial in-farction.Circ Res,2004,95:742-748.
• [22]Erbs S,Linke A,Adams V,et al.Transplantation of blood-de-rived progenitor cells after recanalization of chronic coronary arter-y occlusion First randomized and placebo-controlled study.CircRes,2005,97:756-762.
• [23]Bartunek J,Vanderheyden M,Vandekerckhove B,et al.Intracor-onary injection of CD133-positive enriched bone marrow progeni-tor cells promotes cardiac recovery after recent myocardial infarc-tion feasibility and safety.Circulation,2005,112[supplⅠ]:Ⅰ-178-Ⅰ-183.
• [24]Sven W,Nikos W,Thomas C,et al.Improvement of EndothelialFunction by Systemic Transfusion of Vascular Progenitor Cells.Cir Res,2006,99:e74-e83.
• [25]Erbs S,Linke A,Adams V,et al.Transplantation of blood-de-rived progenitor cells after recanalization of chronic coronary arter-y occlusion.First randomized and placebo-controlled study.CircRes,2005,97:756-762.